Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer
Clinical trial NCT07600164 · RECRUITING
Trial details
- NCT number
- NCT07600164
- Sponsor
- Peking University People's Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-06
- Primary completion
- 2031-12-30
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.